Cargando…

Prevalence of Phosphodiesterase-5 Inhibitor Use in the VHA in 2004 and 2005 Is Twice That of a Commercial Health Plan in 2001

Detalles Bibliográficos
Autores principales: French, Dustin D., Margo, Curtis E., Campbell, Robert R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438309/
https://www.ncbi.nlm.nih.gov/pubmed/17269850
http://dx.doi.org/10.18553/jmcp.2006.12.8.692